Suicide in Stroke Survivors: Epidemiology and Prevention

Drugs and Aging

Volumn 32, Issue 1, 2015, Pages 21-29

  Pompili, Maurizio ^a   Venturini, Paola ^a   Lamis, Dorian A ^b   Giordano, Gloria ^a   Serafini, Gianluca ^c   Belvederi Murri, Martino ^c   Amore, Mario ^c   Girardi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM CARBONATE; SEROTONIN UPTAKE INHIBITOR;

CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DRUG CHOICE; HUMAN; MEDICAL HISTORY; MOOD DISORDER; NONHUMAN; PHARMACEUTICAL CARE; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE PATIENT; STROKE SURVIVOR; SUICIDAL IDEATION; SUICIDE; SURVIVAL; SURVIVOR; SYSTEMATIC REVIEW; ADULT; AGED; ANIMAL; COMPLICATION; FEMALE; MALE; PSYCHOLOGY; RAT; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANIMALS; DEPRESSION; FEMALE; HUMANS; MALE; RATS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STROKE; SUICIDE; SURVIVORS;

EID: 84925511166     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0233-x     Document Type: Review

References (110)

1. Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci. 2010 15;295(1–2):38–40.
2. Mackay J, Mensah G. The Globan burden of stroke. In: The atlas of heart disease and stroke. Geneva: World Health Organization. 2004. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf. Accessed 26 Nov 2014.
3. Lloyd-Jones D, Adams RJ, Brown TM, et al. AHA heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121:46–215.
4. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718–79.
5. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6):85–90.
6. Centers for Disease Control and Prevention. In: CDC Vitalsigns Preventable Deaths from Heart Disease and Stroke. 2013. http://www.cdc.gov/vitalsigns/pdf/2013-09-vitalsigns.pdf. Accessed 26 Nov 2014.
7. Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4–5.
8. Brønnum-Hansen H, Davidsen M, Thorvaldsen P, Danish MONICA Study Group. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131–6.
9. Pompili M, Innamorati M, Venturini P, Serafini G, Lester D, Girardi R. Child abuse as a risk factor for suicide in life: a selective overview. Minerva Psichiatr. 2011;52(1):61–9.
10. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205–28.
11. Juurlink DN, Herrmann N, Szalai JP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004;164(11):1179–84.
12. Quan H, Arboleda-Florez J, Fick GH, et al. Association between physical illness and suicide among the elderly. Soc Psychiatry Psychiatr Epidemiol. 2002;37(4):190–7.
13. Mackenzie TB, Popkin MK. Suicide in medical patient. Int J Psichiatr Med. 1987;17(1):3–22.
14. Arciniegas DB, Anderson CA. Suicide in neurologic illness. Curr Treat Options Neurol. 2002;4(6):457–68.
15. Hadidi N, Treat-Jacoboson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151–62.
16. Beekman AT, Penninx BW, Deeg DJ, Ormel J, Smit JH, Braam AW, Van Tilburg W. Depression in survivor of stroke: a community-based study of prevalence, risk factors and consequences. Soc Psychiatry Psychiatr Epidemiol. 1998;33(10):463–70.
17. Pompili M, Venturini P, Campi S, Seretti ME, Montebovi F, Lamis DA, Serafini G, Amore M, Girardi P. Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS Neurosci Ther. 2012;18(9):711–21.
18. Park SM. Health status and suicidal ideation in Korean elderly: the role of living arrangement. J Ment Health. 2014;23(2):94–8.
19. Shin KM, Cho SM, Hong CH, Park KS, Shin YM, Lim KY, Koh SH. Suicide among the elderly and associated factors in South Korea. Aging Ment Health. 2013;17(1):109–14.
20. Kishi Y, Kosier JT, Robinson RG. Suicidal plans in patients with acute stroke. J Nerv Ment Dis. 1996;184:274–80.
21. Kishi Y, Robinson RG, Kosier JT. Suicidal plans in patients with stroke: comparison between acute-onset and delayed-onset suicidal plans. Int Psychogeriatr. 1996;8:623–34.
22. Pohjasvaara T, Vataja R, Leppävuori A, Kaste M, Erkinjuntti T. Suicidal ideas in stroke patients 3 and 15 months after stroke. Cerebrovasc Dis. 2001;12:21–6.
23. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease, a comparison with healthy community residents. Stroke. 1999;30:2167–73.
24. Santos CO, Caeiro L, Ferro JM, Figueira ML. A study of suicidal thoughts in acute stroke patients. J Stroke Cerebrovasc Dis. 2012;21(8):749–54.
25. Fuller-Thomson E, Tulipano MJ, Song M. The association between depression, suicidal ideation, and stroke in a population-based sample. Int J Stroke. 2012;7(3):188–94.
26. Tang WK, Lu JY, Mok V, Ungvari GS, Wong KS. Is fatigue associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92:1336–1338.
27. Tang WK, Liang H, Mok V, Ungvari GS, Wong KS. Is pain associated with suicidality in stroke? Arch Phys Med Rehabil. 2013;94(5):863–6.
28. Tang WK, Lu JY, Liang H, Chan TT, Mok V, Ungvari GS, Wong KS. Is insomnia associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92(12):2025–7.
29. Chan SS, Lyness JM, Conwell Y. Do cerebrovascular factors confer risk for suicide in later life? A case-control study. Am J Geriatr Psychiatry. 2007; 15:541–544.
30. Yamauchi T, Inagaki M, Yonemoto N, Iwasaki M, Inoue M, Akechi T, Iso H, Tsugane S. Death by Suicide and other externally caused injuries after stroke in Japan (1990–2010): The Japan Public Health Center-Based Prospective Study. Psychosom Med. 2014;76(6):452–9.
31. Stenager EN, Madsen C, Stenager E, Boldsen J. Suicide in patients with stroke: epidemiological study. BMJ. 1998;316:1206.
32. Teasdale TW, Engberg AW. Suicide after a stroke: a population study. J Epidemiol Community Health. 2001;55(12):863–6.
33. Forsström E, Hakko H, Nordström T, Räsänen P, Mainio A. Suicide in patients with stroke: a population-based study of suicide victims during the years 1988–2007 in northern Finland. J Neuropsychiatry Clin Neurosci. 2010;22:182–7.
34. Katayama M, Naritomi H, Oomura M, et al. Case reports of unexpected suicides in patients within 6 months after stroke. Kobe J Med Sci. 2010;56:184–94.
35. Garden FH, Garrison SJ, Jain A. Assessing suicide risk in stroke patients: review of two cases. Arch Phys Med Rehabil. 1990;71:1003–1005.
36. Scott KM, Hwang I, Chiu WT, et al. Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys. Psychosom Med. 2010;72:712–9.
37. Voaklander DC, Rowe BH, Dryden DM, Pahal J, Saar P, Kelly KD. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health. 2008;62:138–46.
38. Placido A, Sposito AC. Association between suicide and cardiovascular disease: time series of 27 years. Int J Cardiol. 2009;135:261–2.
39. Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch Gen Psychiatry. 2012;69(7):671.
40. Crump C, Sundquist K, Sundquist J, Winkleby MA. Sociodemographic, psychiatric and somatic risk factors for suicide: a Swedish national cohort study. Psychol Med. 2014;44(2):279–89.
41. Flaster M, Sharma A, Rao M. Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery. Top Stroke Rehabil. 2013;20(2):139–50.
42. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161(6):1090–5.
43. Yuan H, Zhang N, Wang C, Luo BY, Shi Y, Li J, Zhou Y, Wang Y, Zhang T, Zhou J, Zhao X, Wang Y. Factors of Hamilton depression rating scale (17 items) at 2 weeks correlated with poor outcome at 1 year in patients with ischemic stroke. Neurol Sci. 2014;35(2):171–7.
44. Raskind MA. Diagnosis and treatment of depression comorbid with neurologic disorders. Am J Med. 2008;121(11 Suppl 2):28–37.
45. Hackett ML, Carter G, Crimmins D, Clarke T, Maddock K, Sturm JW. Improving outcomes after stroke clinical pilot trial protocol. Int J Stroke. 2010;5(1):52–6.
46. Baldwin RC. Preventing late-life depression: a clinical update. Int Psychogeriatr. 2010;22(8):1216–24.
47. Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M, Robinson RG. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry. 2011;19(12):1007–15.
48. Bilge C, Koçer E, Koçer A, Türk Börü U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med. 2008;44(1):13–8.
49. Gottfries CG. Late life depression. Eur Arch Psychiatry Clin Neurosci. 2001;251(2):57–61.
50. Carota A, Bogousslavsky J. Poststroke depression. Adv Neurol. 2003;92:435–45.
51. Capaldi VF 2nd, Wynn GH. Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients. Psychol Res Behav Manag. 2010;3:109–18.
52. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window? J Nerv Ment Dis. 2003;191(10):645–52.
53. Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Arch Phys Med Rehabil. 2006;87(6):793–8.
54. Cravello L, Caltagirone C, Spalletta G. The SNRI venlafaxine improbe emotional unawareness in patients with post-stroke depression. Hum Psychopharmacol. 2009;24(4):331–6.
55. Conn DK, Steingart AB. Diagnosis and management of late life depression: a guide for the primary care physician. Int J Psychiatry Med. 1997;27(3):269–81.
56. Shima S. The efficacy of antidepressants in post-stroke depression. Keio J Med. 1997;46(1):25–6.
57. Pompili M, Rihmer Z, Innamorati M, Lester D, Girardi P, Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev Neurother. 2009;9(1):109–36.
58. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;16(3):CD003689
59. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil. 1997;11(2):114–22.
60. Harmandayan M, Romanowicz M, Sola C. Successful use of ECT in post-stroke depression. Gen Hosp Psychiatry. 2012;34(1):102.e5–6.
61. Riva-Posse P, Hermida AP, McDonald WM. The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression. Psychiatr Clin North Am. 2013;36(4):607–30.
62. Huang H, Chen K, Guo T, Zhang Y, Qu W, Zhou Z, Liu G, Chen L. Treatment with carotid angioplasty stent placement for post-stroke depression compared to antidepressants. Neurosciences (Riyadh). 2012;17(1):53–6.
63. Joubert J, Joubert L, Reid C, Barton D, Cumming T, Mitchell P, House M, Heng R, Meadows G, Walterfang M, Pantelis C, Ames D, Davis S. The positive effect of integrated care on depressive symptoms in stroke survivors. Cerebrovasc Dis. 2008;26(2):199–205.
64. Graven C, Brock K, Hill K, Ames D, Cotton S, Joubert L. From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke. BMC Neurol. 2011;18(11):73.
65. Hawton K, van Heeringen K. Suicide. Lancet. 2009;373:1372–81.
66. Ellis C, Zhao Y, Egede L. Depression and increased risk of death in adults with stroke. J Psychosom Res. 2010;68:545–51.
67. Staub F, Bogousslavsky J. Post-stroke depression or fatigue. Eur Neurol. 2001;45:3–5.
68. Saravane D, Feve B, Frances Y, et al. Drawing up guidelines for the attendance of physical health of patients with severe mental illness. Encephale. 2009;35:330–9.
69. Williams LS. Depression and stroke: cause or consequence? Semin Neurol. 2005;25:396–409.
70. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156:1417–20.
71. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368–73.
72. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–9.
73. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996;19:1097–102.
74. Mezuk B, Eaton WW, Golden SH, Ding Y. The influence of educational attainment on depression and risk of type 2 diabetes. Am J Public Health. 2008;98:1480–5.
75. McElroy SL, Frye MA, Suppes T. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63:207–13.
76. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005;7:424–30.
77. Shah A, Shen N, El-Mallakh RS. Weight gain occurs after onset of bipolar illness in overweight bipolar patients. Ann Clin Psychiatry. 2006;18:239–41.
78. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, del Miller D, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry. 2008;20:131–7.
79. Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007;68:917–23.
80. Yates WR, Wallace R. Cardiovascular risk factors in affective disorder. J Affect Disord. 1987;12:129–34.
81. Johannessen L, Strudsholm U, Foldager L, Munk-Jorgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95:13–7.
82. Patten SB, Williams JV, Lavorato DH, Modgill G, Jette N, Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry. 2008;30:407–13.
83. Davis J, Fujimoto RY, Juarez DT, Hodges KA, Asam JK. Major depression associated with rates of cardiovascular disease state transitions. Am J Manag Care. 2008;14:125–8.
84. Meyer CM, Armenian HK, Eaton WW, Ford DE. Incident hypertension associated with depression in the Baltimore epidemiologic catchment area follow-up study. J Affect Disord. 2004;83:127–33.
85. Kim JM, Kim SW, Kang HJ, Bae KY, Shin IS, Kim JT, Park MS, Park SW, Kim YH, Cho KH, Yoon JS. Serotonergic genes and suicidal ideation 2 weeks and 1 year after stroke in Korea. Am J Geriatr Psychiatry. 2013. doi:S1064-7481(13)00260-1.
86. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;. doi:10.1136/bmj.d4551.
87. De Coster L, Leentjens AF, Lodder J, Verhey FR. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach. Int J Geriatr Psychiatry. 2005;20:358–62.
88. Prithard C, Hansen L. Comparison of suicide in people aged 65–74 and 75+ by gender in England and Wales and the major Western countries 1979–1999. Int J Geriatr Psychiatry. 2005;20:17–25.
89. Van de Port IG, Kwakkel G, Schepers VP, Heinemans CT, Lindeman E. Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis. 2007;23:40–5.
90. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS. Fluoxetine is not effective in the treatment of post-stroke fatigue: a doubleblind, placebo-controlled study. Cerebrovasc Dis. 2007;23:103–8.
91. Zorowitz RD, Smout RJ, Gassaway JA, Horn SD. Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil. 2005;12:37–49.
92. Kong KH, Woon VC, Yang SY. Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil. 2004;85:35–40.
93. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008;4:145–54.
94. Lee HC, Lin HC, Tsai SY. Severely depressed young patients have over five times increased risk for stroke: a 5-year follow- up study. Biol Psychiatry. 2008;15:912–5.
95. Nuyen J, Spreeuwenberg P. Impact of preexisting depression on length of stay and discharge destination among patients hospitalized for acute stroke. Stroke. 2008;39:132–8.
96. Sokero T, Melartin T, Rytsala H, Leskela U, Lestela-Mielonen L, Isometsa E. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry. 2005;186:314–8.
97. Joiner T, Conwell Y, Fitzpatrick K, Witte T, Schmidt N, Berlim M, Fleck M, Rudd M. Four studies on how past and current suicidality relate even when “everything but the kitchen sink” is covaried. J Abnorm Psychol. 2005;114:291–303.
98. Fawcett J, Scheftner W, Fogg L, Clark D, Youn M, Hedeker D, Gibbons R. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:1189–94.
99. Younes N, Melchior M, Turbelin C, Blanchon T, Hanslik T, ChanChee C. Attempted and completed suicide in primary care: not what we expected? J Affect Disord. 2015;170:150–4.
100. Barbui C, Patten SB. Antidepressant dose and the risk of deliberate self-harm. Epidemiol Psychiatr Sci. 2014;14:1–3.
101. Pompili M, Tondo L, Baldessarini RJ. Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin Neuropsychiatry. 2005;2(1):66–72.
102. Möller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, Tandon R, Versiani M. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 3):3–23.
103. Baldessarini RJ, Pompili M, Tondo L, Tsapakis E, Soldani F, Faedda GL, Hennen J. Antidepressants and suicidal behavior: are we hurting or helping? Clin Neuropsychiatry. 2005;2(1):75.
104. Thome J, Foley P. Agomelatine: an agent against anhedonia and abulia? J Neural Transm. 2013. doi: 10.1007/s00702-013-1126-6.
105. Niedermaier N, Bohrer E, Schulte K, Schlattmann P, Heuser I. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry. 2004;65(12):1619–23.
106. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44(3):216–21.
107. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160(10):1823–9.
108. Fregni F, Pascual-Leone A. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders. Curr Psychiatry Rep. 2005;7(5):381–90.
109. Kim BR, Kim DY, Chun MH, Yi JH, Kwon JS. Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: a double-blind, sham-controlled trial. Am J Phys Med Rehabil. 2010;89(5):362–8. doi:10.1097/PHM.0b013e3181d8a5b1.
110. Bates KA, Rodger J. Repetitive transcranial magnetic stimulation for stroke rehabilitation-potential therapy or misplaced hope? Restor Neurol Neurosci. 2014;. doi:10.3233/RNN-130359.